Notícias Eulerpool Nxera Pharma Co

Nxera Pharma Co Eulerpool-AFX

Nxera Pharma Co Notícias de ações

Nxera Pharma Co é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Nxera Pharma Co nós reunimos aqui.

• 2 de setembro ·

  Yahoo
  Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 28 de agosto ·

  Yahoo
  Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
• 9 de agosto ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2024
• 9 de julho ·

  Yahoo
  Nxera Pharma Webinar Presentation for Q2 FY2024 Financial Results
• 9 de julho ·

  SeekingAlpha
  Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
• 27 de junho ·

  Yahoo
  Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
• 18 de junho ·

  Yahoo
  Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
• 30 de maio ·

  Yahoo
  Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
• 30 de maio ·

  Yahoo
  Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
• 9 de maio ·

  Yahoo
  Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults